Mercado de Alimentos Médicos do Médio Oriente e África para Erros Inatos do Metabolismo – Tendências da Indústria e Previsão para 2030

Médio Oriente e África Alimentos Médicos para Erros Inatos da Análise e Tamanho do Mercado do Metabolismo

Para um indivíduo com uma determinada condição genética, a terapia nutricional para erros inatos do metabolismo satisfaz entre 85% e 90% das suas necessidades nutricionais. Estes suplementos têm efeitos adversos insignificantes, tornando-os adequados para utilização por doentes de todas as idades. Os seguros médicos privados nos EUA e em alguns outros países começaram recentemente a oferecer programas de reembolso para a utilização de alimentos médicos específicos. Por conseguinte, a crescente adoção de alimentos médicos e suplementos nutricionais potencia o crescimento do mercado.  

A Data Bridge Market Research analisa uma taxa de crescimento no mercado de alimentos médicos para erros inatos do metabolismo no período de previsão 2023-2030. O CAGR esperado do mercado de alimentos médicos para os erros inatos do metabolismo tende a rondar os 6,70% no período de previsão mencionado. O mercado está avaliado em 103,8 milhões de dólares em 2022 e cresceria até 174,39 milhões de dólares até 2030. Para além dos insights de mercado, como o valor de mercado, taxa de crescimento, segmentos de mercado, cobertura geográfica, participantes no mercado e cenário de mercado, o O relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge inclui também uma análise especializada aprofundada, epidemiologia dos doentes, análise de pipeline, análise de preços e estrutura regulamentar.

Médio Oriente e África Alimentos Médicos para Erros Inatos do Escopo e Segmentação do Mercado do Metabolismo

Definição de mercado

Os erros metabólicos inatos são o tipo de distúrbio em que o corpo não consegue converter os alimentos em energia. No caso de erros inatos do metabolismo, os alimentos medicinais são amplamente utilizados como opções de tratamento, e os produtos acessíveis no mercado são regulados por estatutos oficiais e regulamentares de alimentos e suplementos alimentares. Não há produção de enzima específica, que é a principal responsável pela decomposição de certas substâncias devido a mutações genéticas.  

Médio Oriente e África Alimentos médicos para erros inatos da dinâmica do mercado do metabolismo

Motoristas

• Aumento da preferência por suplementos dietéticos

Os suplementos nutracêuticos e os alimentos recomendados para fins medicinais estão a tornar-se cada vez mais populares do que os medicamentos terapêuticos baseados em enzimas. A tendência dos medicamentos para suplementos alimentares e alimentos medicinais deve-se provavelmente ao aumento dos custos de saúde e à preferência dos clientes por métodos de gestão de doenças baratos, rápidos e eficientes. Portanto, este fator aumenta o crescimento do mercado.

• Aumento do uso de alimentos médicos

Medical foods are used as the ultimate treatment options for inborn metabolic errors, and the products available on the market are regulated under regulatory food and diet supplement statuses. The nutritional treatment for inherited metabolic errors meets between 85% and 90% of a person's nutritional needs. Additionally, these supplements have nearly no side effects, making them appropriate for patients of all age groups. Presently, private medical insurers in the U.S. and a few other countries have begun to provide reimbursement programmes for the consumption of certain medical foods. Therefore, increasing adoption of medical food and nutrient supplements is anticipated to boost the market growth during the forecast period 2023-2030. This factor improves the market growth.

Opportunities

• Increased Product Launches and Agreements

There has been increasing product launches and agreements between market players,ncreasing the market's growth. For instance, Nutricia opened a sustainable plant in Netherlands in March 2019. The Nutricia Cuijk plant was a huge investment and has increased the volume of specialized infant formula and the market's revenue generation. Furthermore, in June, Mead Johnson andCompany, LLC. announced the merger with Reckitt Benckiser Group plc (RB).  It was anticipated that the Mead Johnson brand and business continued to grow with Reckitt Benckiser plc groups’ good innovation and marketing process. Thus, this factor created much opportunity for the market growth.  

Restraints/Challenges

• Inadequate Reimbursement Policies

Even though several products were launched, but not all the products have been launched at a cheap price. An inadequate reimbursement scenario is anticipated to restrict the use of medical food and decrease the growth of the medical food market during the forecast period 2023-2030. Thus, this hampers the market growth.

This medical foods for inborn errors of metabolism market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the medical foods for inborn errors of metabolism market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Scope

The medical foods for inborn errors of metabolism market is segmented on the basis of products, age group, diseases, form, packaging and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

• Amino Acid
• Glytactin with GMP Amino Acid-Modified Infant Formula with Iron
• Low-Calcium/Vitamin D-Free Infant Formula with Iron
• Low Protein Food
• Others

 Age Group

• Infants
• Weaning
• Adolescent
• Adults

 Diseases

• Phenylketonuria (PKU)
• Maple Syrup Urine Disease (MSUD)
• Homocystinuria
• Methylmalonic Acidemia
• Organic Acidurias
• Propionic Acidemia
• Isovaleric Acidemia
• Disorders of Leucine Metabolism
• Glutaric Acidemia Type I Renal Disease
• Tyrosinemia Types I and II
• Urea Cycle Disorders
• Others

 Forms

• Powder
• Liquids
• Gels and Others

 Packaging

• Can
• Jar
• Packets
• Bottle
• Others

Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Drugs Stores
• Online Pharmacies
• Others

Medical Foods for Inborn Errors of Metabolism Market Regional Analysis/Insights

The medical foods for inborn errors of metabolism market is analyzed and market size insights and trends are provided by mechanism, category, treatment, software, services, app accessibility, app type, application, patients as referenced above.

The major countries covered in the medical foods for inborn errors of metabolism market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Saudi Arabia is anticipated to grow with the highest CAGR in the forecast period because of increased healthcare expenditure in this region and patient are more shifted in taking medical food rather than enzymatic therapy. Disposable income is high through which it is feasible for the patients to afford the medical foods in their regular diet.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Share Analysis

O cenário competitivo do mercado de alimentos médicos para erros inatos do metabolismo fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença no Médio Oriente e em África, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura do produto e amplitude, domínio de aplicação. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de alimentos médicos para os erros congénitos do metabolismo.

Os principais players que operam no mercado de alimentos médicos para erros inatos do metabolismo incluem:

• Nestlé Health Science (Suíça)
• Nutricia (Holanda)
• Consolo Nutrição (EUA)
• Abbott (EUA)
• Mead Johnson andCompany, LLC.(EUA)
• BioMarin Farmacêutica (EUA)
• Ajinomoto Cambrooke, Inc.
• Poa Pharma (Suécia)
• PKU-MDmil (EUA)
• Dr.Schar AG/SPA Primus Pharmaceuticals, Inc.
• A Pristine Organics Unip. Lda. (Índia)
• ABRIL (EUA)
• Ener-G Foods, INC (EUA)
• Promin Metabolics (Reino Unido)

SKU-53802